R1 RCM (NASDAQ:RCM) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, August 4th. Analysts expect the company to announce earnings of $0.02 per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.
R1 RCM (NASDAQ:RCM) last posted its earnings results on Tuesday, May 5th. The healthcare provider reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). The firm had revenue of $320.50 million for the quarter, compared to the consensus estimate of $318.76 million. R1 RCM had a net margin of 2.44% and a return on equity of 174.42%. The firm’s revenue was up 16.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.04) earnings per share. On average, analysts expect R1 RCM to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
NASDAQ RCM opened at $13.67 on Friday. The company has a debt-to-equity ratio of 14.63, a quick ratio of 1.18 and a current ratio of 1.18. The company has a market capitalization of $1.59 billion, a P/E ratio of -683.16, a P/E/G ratio of 11.47 and a beta of 0.53. R1 RCM has a one year low of $7.12 and a one year high of $13.99. The stock has a 50 day moving average price of $12.21 and a 200-day moving average price of $11.37.
A number of analysts recently issued reports on the company. Zacks Investment Research downgraded R1 RCM from a “hold” rating to a “sell” rating in a research report on Friday. SVB Leerink assumed coverage on R1 RCM in a research report on Monday, April 13th. They issued a “market perform” rating and a $10.00 price target for the company. BidaskClub upgraded R1 RCM from a “hold” rating to a “buy” rating in a research report on Wednesday, July 15th. TheStreet upgraded R1 RCM from a “c” rating to a “b-” rating in a research report on Wednesday. Finally, Royal Bank of Canada assumed coverage on R1 RCM in a research report on Monday, April 20th. They issued an “outperform” rating and a $12.00 price target for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $13.43.
About R1 RCM
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Recommended Story: What’s a Black Swan?
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.